• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Chief Executive Officer Davis Kirk A bought $49,999 worth of shares (7,143 units at $7.00), increasing direct ownership by 32% to 29,474 units (SEC Form 4)

    8/12/24 2:32:46 PM ET
    $HHS
    Advertising
    Consumer Discretionary
    Get the next $HHS alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Davis Kirk A

    (Last) (First) (Middle)
    1 EXECUTIVE DR

    (Street)
    CHELMSFORD MA 01824

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    HARTE HANKS INC [ HHS ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Executive Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    08/12/2024
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 08/12/2024 P 7,082(1) A $7 29,413 D
    Common Stock 08/12/2024 P 61(1) A $6.96 29,474 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Option to buy Common Shares $5.59 06/19/2024 08/14/2033 Common Stock 240,000(2) 240,000 I NQ stock options granted and held by Harte Hanks, Inc. until exercised.
    Explanation of Responses:
    1. Participant purchased common shares.
    2. NQ stock options granted on August 14, 2023 under the Harte Hanks, Inc. 2023 Inducement Equity Incentive Plan. The options vest and become exercisable as to 1/3rd of the underlying shares on each of the first three anniversaries of June 19, 2023.
    Remarks:
    /s/ Robert Wyman, Attorney-in-fact for Kirk Davis 08/12/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $HHS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HHS

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HHS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Rosenbach Gary Stephen bought $44,989 worth of shares (8,400 units at $5.36) (SEC Form 4)

      4 - HARTE HANKS INC (0000045919) (Issuer)

      5/30/25 8:02:01 PM ET
      $HHS
      Advertising
      Consumer Discretionary
    • Director Radoff Bradley Louis bought $100,389 worth of shares (17,225 units at $5.83), increasing direct ownership by 5% to 391,399 units (SEC Form 4)

      4 - HARTE HANKS INC (0000045919) (Issuer)

      12/6/24 4:45:53 PM ET
      $HHS
      Advertising
      Consumer Discretionary
    • Director Radoff Bradley Louis bought $241,551 worth of shares (42,775 units at $5.65), increasing direct ownership by 13% to 374,174 units (SEC Form 4)

      4 - HARTE HANKS INC (0000045919) (Issuer)

      12/5/24 6:07:29 PM ET
      $HHS
      Advertising
      Consumer Discretionary

    $HHS
    Financials

    Live finance-specific insights

    See more
    • Harte Hanks Reports Third Quarter 2024 Results

      CHELMSFORD, MA / ACCESSWIRE / November 14, 2024 / Harte Hanks, Inc. (NASDAQ:HHS), a leading global customer experience company focused on bringing companies closer to customers for over 100 years, today announced financial results for the third quarter ended September 30, 2024.Kirk Davis, Chief Executive Officer, stated: "In Q3, we continued to focus on improving our sales execution. As we approach 2025, we are strategically positioned to capitalize on key growth opportunities through our newly established Customer Excellence and Growth (CEG) division. Under the leadership of our company's first Chief Customer and Data Officer, this division unifies our sales and customer organizations, focu

      11/14/24 4:05:00 PM ET
      $HHS
      Advertising
      Consumer Discretionary
    • Harte Hanks to Report Third Quarter 2024 Financial Results on November 14, 2024

      CHELMSFORD, MA / ACCESSWIRE / October 31, 2024 / Harte Hanks, Inc. (NASDAQ:HHS), a leading global customer experience company focused on bringing companies closer to customers for over 100 years, announced today that the company will release financial results for the third quarter of 2024, the period ended September 30, 2024, on Thursday, November 14, 2024, after the close of the market.The Company will host a conference call and live webcast to discuss these results at 4:30 p.m. EDT on the same day. Interested parties may access the webcast at https://www.webcaster4.com/Webcast/Page/2810/51436 or access the conference call by dialing 888-506-0062 in the United States or 973-528-0011 from ou

      10/31/24 8:00:00 AM ET
      $HHS
      Advertising
      Consumer Discretionary
    • Harte Hanks Announces New Leadership in Sales Transition

      CHELMSFORD, MA / ACCESSWIRE / September 16, 2024 / Harte Hanks, Inc. (NASDAQ:HHS), a global leader in customer experience for over 100 years, today announced a leadership transition within its sales organization.Jason Chapman, a seasoned executive known for driving business transformation and leading global go-to-market teams, has been appointed as Interim Global Head of Sales and Marketing. Chapman takes over for Kelly Waller, who has stepped down as part of a planned departure due to personal reasons.Kirk Davis, Chief Executive Officer, remarked: "The entire Harte Hanks team fully supports Kelly in her decision and wishes her the best as she moves forward. Kelly's leadership has been instr

      9/16/24 8:05:00 AM ET
      $HHS
      Advertising
      Consumer Discretionary